Drugs / Trivalent OPV Birmex
last change Jan 2014 re-read 3 minutes ago

Trivalent OPV Birmex

Vaccine

Developed for
poliomyelitis
Investigated by
Birmex

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01870206 Jun → Dec 2013 poliomyelitis Birmex Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Trivalent OPV Birmex ClinicalTrials.gov intervention name — accepted as the source's own label NCT01870206 ↗
Modality Vaccine “OPV vaccine produced in Vero cells by Birmex” NCT01870206 ↗